Clinical and cost‐effectiveness of primary prevention of Type 2 diabetes in a ‘real world’ routine healthcare setting: model based on the KORA Survey 2000

Icks, Andrea; Rathmann, Wolfgang; Haastert, B; Gandjour, Afschin; Holle, Rolf; John, Jürgen; Giani, Guido

doi:10.1111/j.1464-5491.2007.02108.x

Cited by 40 publications

(49 citation statements)

References 25 publications

(42 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This was shown to be the case, but intervention was cost-effective in both groups, with costs per QALY of US$8181 and US$9511, respectively. 263 applied the results of the DPP to the German population in Augsberg, modelling no intervention, lifestyle and metformin, with a 3-year timescale. 263 However, they tried to model a 'real-life' scenario with pessimistic estimates of participation.…”

Section: Hoerger Et Al (2007)mentioning

confidence: 99%

“…263 applied the results of the DPP to the German population in Augsberg, modelling no intervention, lifestyle and metformin, with a 3-year timescale. 263 However, they tried to model a 'real-life' scenario with pessimistic estimates of participation. They assumed from previous experience in Germany, and elsewhere, that participation in screening would be low (30-35%), adherence to lifestyle would be poor (in a German disease management programme only 40% of patients with diabetes followed lifestyle training), and obese patients would have even poorer adherence (only 20% participated in a lifestyle programme to lose weight).…”

Section: Hoerger Et Al (2007)mentioning

confidence: 99%

“…■ Different costings, and in particular whether the cost of screening was included in the cost of prevention of diabetes. Icks et al (2007) 263 estimated that 36% of the cost came from the screening. ■ Different assumptions on duration of benefit, with pessimists assuming that the benefit would end when the intervention did and optimists assuming that they would last for life.…”

mentioning

confidence: 99%

“…Icks et al (2007) 263 assumed that the cost-effectiveness of a DPP-style intervention would be less in routine care because adherence to lifestyle measures would be poorer and shorter.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

Gillett

Royle²,

Snaith³

et al. 2012

Health Technol Assess

111

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service' . The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projec...

show abstract

Section: Hoerger Et Al (2007)mentioning

confidence: 99%

Section: Hoerger Et Al (2007)mentioning

confidence: 99%

mentioning

confidence: 99%

“…Icks et al (2007) 263 assumed that the cost-effectiveness of a DPP-style intervention would be less in routine care because adherence to lifestyle measures would be poorer and shorter.…”

mentioning

confidence: 99%

See 2 more Smart Citations

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

Gillett

Royle²,

Snaith³

et al. 2012

Health Technol Assess

111

View full text Add to dashboard Cite

show abstract

“…Un diabético cuesta hasta 2,5 veces el costo de un no diabético 22,23 , incluyendo pacientes hospitalizados [24][25][26] . Pacientes considerados prediabéticos, que progresan a DM tipo 2, aumentan sus costos de atención 27 , los que podrían ser efectivamente evitados 28 . El número de complicaciones aumenta el costo de atención: la literatura anglosajona calcula costos directos según presencia de complicaciones [29][30][31] .…”

unclassified

Niveles de hemoglobina glicosilada y diferencia en el gasto en salud de pacientes diabéticos: un estudio econométrico

et al. 2014

View full text Add to dashboard Cite

The economics of diabetes care: a global perspective

Williams

2015

International Textbook of Diabetes Mellitus

View full text Add to dashboard Cite

Clinical and cost‐effectiveness of primary prevention of Type 2 diabetes in a ‘real world’ routine healthcare setting: model based on the KORA Survey 2000

Cited by 40 publications

References 25 publications

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation.

Niveles de hemoglobina glicosilada y diferencia en el gasto en salud de pacientes diabéticos: un estudio econométrico

The economics of diabetes care: a global perspective

Contact Info

Product

Resources

About